Journal of the American College of Emergency Physicians open · 2026
Tachycardia and Positive Amphetamine Screen are Associated With True Positive-Methamphetamine Exposures in Pediatric Patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gans Dana, King William, Brewer Lauren, Nichols Michele, Monroe Kathy, Rushton William
Аннотация
OBJECTIVES: Methamphetamine exposure is a high-risk condition in pediatric patients. Standard screening often begins with a rapid urine drug screen (UDS) immunoassay, which can yield false-positive results. Confirmatory testing with gas chromatography and mass spectrometry is more accurate, but is not always readily available. This study aimed to identify clinical factors associated with true methamphetamine positivity.
METHODS: We conducted a retrospective cohort study at a single children's hospital, reviewing cases from January 1, 2018, to December 31, 2023. Patients with a positive screening test for methamphetamine, with results from confirmatory testing, were included. Demographic characteristics, laboratory values, urine findings, and clinical presentations were analyzed.
RESULTS: Of 205 patients with a positive UDS, 52 (25%) underwent confirmatory testing. Most were male (n = 28, 54%), and 33 patients (63%) were 0 to 5 years old. Confirmatory testing was positive for methamphetamine in 32 cases (62%). Tachycardia was present in 31 (60%) patients, and 26 (81%) of these were confirmed methamphetamine positive (P < .001). Amphetamine copositivity on the UDS was seen in 26 (50%) patients, 25 (96%) of whom were confirmed methamphetamine positive (P < .001). Hypokalemia, elevated creatine kinase level, elevated lactate level, and hyperthermia trended toward association, but did not reach statistical significance.
CONCLUSION: In this cohort, false-positive methamphetamine results on rapid UDSs were common. Tachycardia and concurrent amphetamine positivity were strongly associated with confirmed methamphetamine exposure. Clinicians should be aware of the limitations of immunoassay-based screening and consider confirmatory testing when available.
METHODS: We conducted a retrospective cohort study at a single children's hospital, reviewing cases from January 1, 2018, to December 31, 2023. Patients with a positive screening test for methamphetamine, with results from confirmatory testing, were included. Demographic characteristics, laboratory values, urine findings, and clinical presentations were analyzed.
RESULTS: Of 205 patients with a positive UDS, 52 (25%) underwent confirmatory testing. Most were male (n = 28, 54%), and 33 patients (63%) were 0 to 5 years old. Confirmatory testing was positive for methamphetamine in 32 cases (62%). Tachycardia was present in 31 (60%) patients, and 26 (81%) of these were confirmed methamphetamine positive (P < .001). Amphetamine copositivity on the UDS was seen in 26 (50%) patients, 25 (96%) of whom were confirmed methamphetamine positive (P < .001). Hypokalemia, elevated creatine kinase level, elevated lactate level, and hyperthermia trended toward association, but did not reach statistical significance.
CONCLUSION: In this cohort, false-positive methamphetamine results on rapid UDSs were common. Tachycardia and concurrent amphetamine positivity were strongly associated with confirmed methamphetamine exposure. Clinicians should be aware of the limitations of immunoassay-based screening and consider confirmatory testing when available.